| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 23,848 | 17,444 | 14,323 | | Selling General and Administrative | 29,791 | 25,219 | 17,160 | | Non Recurring |
-
|
-
| 646 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (53,639) | (42,664) | (32,128) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,909 | 3,294 | 1,916 | | Earnings Before Interest And Taxes | (51,730) | (39,370) | (30,212) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (51,730) | (39,370) | (30,212) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (51,730) | (39,370) | (30,212) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (51,730) | (39,370) | (30,212) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($51,730) | ($39,370) | ($30,212) |
|
1.48% Nasdaq 
0.05 (0.75%) 
Income Statement
